Medication to Treat Agitation for Alzheimer Disease Shows Mixed Results
Medication to Treat Agitation for Alzheimer Disease Shows Mixed Results
Anton P. Porsteinsson, M.D., of the University of Rochester School of Medicine and Dentistry, Rochester, N.Y., and colleagues randomized 186 patients with probable Alzheimer disease without major depression and clinically… Continue reading
SLC1 Glutamate Transporters and Diseases: Psychiatric Diseases and Pathological Pain.
SLC1 Glutamate Transporters and Diseases: Psychiatric Diseases and Pathological Pain.
Curr Mol Pharmacol. 2013 Jul 22;
Nakagawa T, Kaneko S
The solute carrier family 1 (SLC1) consists of two neutral amino acid transporters and five high-affinity excitatory amino acid… Continue reading
[Analysis of Clinical Pathway in Changing and Disabling Neurological Diseases.]
[Analysis of clinical pathway in changing and disabling neurological diseases.]
Rev Neurol (Paris). 2013 Apr 24;
Cordesse V, Jametal T, Guy C, Lefebvre S, Roussel M, Ruggeri J, Schimmel P, Holstein J, Meininger V
Neurological diseases are characterized by… Continue reading
Late-Life Depression, Mild Cognitive Impairment, and Dementia.
Late-life depression, mild cognitive impairment, and dementia.
JAMA Neurol. 2013 Mar 1; 70(3): 374-82
Richard E, Reitz C, Honig LH, Schupf N, Tang MX, Manly JJ, Mayeux R, Devanand D, Luchsinger JA
To evaluate the association of late-life depression… Continue reading
A New Fork in the Road: Lymphedema Bypass.
A New Fork in the Road: Lymphedema Bypass.
Adv Skin Wound Care. 2013 Mar 8;
Salcido RS
The clinical spectrum of sport-related traumatic brain injury.
Nat Rev Neurol. 2013 Mar 12;
Jordan BD
Acute… Continue reading